Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PRFX | PainReform Ltd.

Index- P/E- EPS (ttm)-9.05 Insider Own5.55% Shs Outstand1.56M Perf Week-8.74%
Market Cap5.64M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.14M Perf Month-25.89%
Income-9.80M PEG- EPS next Q- Inst Own32.00% Short Float / Ratio0.38% / 0.00 Perf Quarter-27.55%
Sales- P/S- EPS this Y-11.70% Inst Trans1.39% Short Interest0.00M Perf Half Y-35.47%
Book/sh6.29 P/B0.56 EPS next Y- ROA-85.10% Target Price30.00 Perf Year-45.96%
Cash/sh3.21 P/C1.11 EPS next 5Y- ROE-96.90% 52W Range3.40 - 26.41 Perf YTD-13.98%
Dividend- P/FCF- EPS past 5Y-28.60% ROI- 52W High-86.56% Beta0.20
Dividend %- Quick Ratio7.60 Sales past 5Y- Gross Margin- 52W Low4.29% ATR0.44
Employees6 Current Ratio7.60 Sales Q/Q- Oper. Margin- RSI (14)33.49 Volatility4.67% 7.45%
OptionableNo Debt/Eq0.00 EPS Q/Q-16.40% Profit Margin- Rel Volume0.01 Prev Close3.82
ShortableYes LT Debt/Eq0.00 EarningsAug 10 AMC Payout- Avg Volume1.31M Price3.55
Recom2.00 SMA20-16.01% SMA50-38.12% SMA200-36.44% Volume14,102 Change-7.07%
Sep-11-23 08:30AM
Sep-07-23 10:00AM
Sep-05-23 08:30AM
Aug-10-23 04:05PM
09:00AM Loading…
Jul-19-23 09:00AM
Jul-14-23 02:35PM
Jul-12-23 09:05AM
Jul-03-23 09:01AM
Jun-15-23 08:30AM
Jun-07-23 04:30PM
May-18-23 09:00AM
May-15-23 04:45PM
May-02-23 08:30AM
May-01-23 08:30AM
09:00AM Loading…
Apr-17-23 09:00AM
Mar-28-23 09:10AM
Mar-16-23 08:00AM
Mar-14-23 08:00AM
Feb-07-23 04:05PM
Nov-15-22 08:30AM
Nov-08-22 08:30AM
Oct-04-22 09:00AM
Sep-01-22 08:00AM
Aug-16-22 08:05AM
May-17-22 07:00AM
Apr-12-22 09:00AM
Mar-21-22 09:25AM
Mar-17-22 08:00AM
08:30AM Loading…
Dec-14-21 08:30AM
Nov-22-21 11:58AM
Nov-16-21 08:00AM
Oct-14-21 08:30AM
Aug-16-21 08:00AM
Jun-15-21 12:46PM
May-24-21 06:35AM
May-13-21 08:15AM
Mar-18-21 09:15AM
Mar-11-21 10:43AM
Mar-08-21 09:00AM
Jan-07-21 08:30AM
Jan-06-21 08:30AM
Jan-04-21 08:30AM
Nov-23-20 08:30AM
Nov-12-20 09:00AM
Nov-05-20 08:30AM
Oct-19-20 09:00AM
Sep-29-20 07:30AM
Sep-09-20 02:15PM
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.